Benzinga's Top #PreMarket Gainers
Ophthotech (NASDAQ: OPHT) soared 23.97% to $39.00 in the pre-market trading after the company reported that it has entered into an ex-US licensing and commercialization deal with Novartis Pharmaceuticals.
NewLead Holdings (NASDAQ: NEWL) shares jumped 12.82% to $2.20 after surging 209.72% on Monday.
Dendreon (NASDAQ: DNDN) shares jumped 10.28% to $2.36 in pre-market trading after the company announced the presentation of PROVENGE ProACT and IMPACT studies data.
Clovis Oncology (NASDAQ: CLVS) shares climbed 7.45% to $61.00 in the pre-market trading session after the company reported that it has received breakthrough therapy designation for CO-1686.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.